Microbio Co., Ltd. (TPEX: 4128)
Taiwan
· Delayed Price · Currency is TWD 33.05
-0.55 (-1.64%)
Dec 20, 2024, 1:30 PM CST
Microbio Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 1,626 | 1,554 | 1,690 | 1,745 | 1,572 | 1,441 | Upgrade
|
| Other Revenue | 55.47 | 37.47 | 31.44 | 37 | 29.18 | 24.99 | Upgrade
|
| Revenue | 1,682 | 1,591 | 1,722 | 1,782 | 1,601 | 1,466 | Upgrade
|
| Revenue Growth (YoY) | 4.64% | -7.58% | -3.38% | 11.28% | 9.21% | 1.23% | Upgrade
|
| Cost of Revenue | 1,034 | 987.51 | 1,031 | 1,043 | 967.67 | 886.25 | Upgrade
|
| Gross Profit | 648.19 | 603.88 | 691.3 | 739.37 | 633.73 | 580.06 | Upgrade
|
| Selling, General & Admin | 531.31 | 519.62 | 536.69 | 1,041 | 1,387 | 643.16 | Upgrade
|
| Research & Development | 376.53 | 404.49 | 264.91 | 861.54 | 352.97 | 98.16 | Upgrade
|
| Other Operating Expenses | - | - | - | -0.35 | - | - | Upgrade
|
| Operating Expenses | 907.84 | 924.11 | 801.61 | 1,902 | 1,740 | 741.86 | Upgrade
|
| Operating Income | -259.65 | -320.22 | -110.31 | -1,163 | -1,106 | -161.8 | Upgrade
|
| Interest Expense | -9.89 | -7.38 | -6.1 | -6.22 | -7.33 | -9.48 | Upgrade
|
| Interest & Investment Income | 95.26 | 92.55 | 47.4 | 40.85 | 61.27 | 77.98 | Upgrade
|
| Earnings From Equity Investments | -692.82 | -1,052 | 235.94 | 719.45 | 1,652 | -219.39 | Upgrade
|
| Currency Exchange Gain (Loss) | -22.53 | 23.33 | 124.45 | -40.11 | -105.99 | 29.13 | Upgrade
|
| Other Non Operating Income (Expenses) | 6.88 | 5.31 | 8.7 | 14.45 | 27.32 | 8.75 | Upgrade
|
| EBT Excluding Unusual Items | -882.75 | -1,259 | 300.08 | -434.35 | 521.04 | -274.81 | Upgrade
|
| Gain (Loss) on Sale of Investments | 9.19 | 65.97 | 22.39 | -8.19 | 6.07 | 27.34 | Upgrade
|
| Gain (Loss) on Sale of Assets | -186.26 | -186.26 | -171.46 | -1.43 | -2.69 | -1.37 | Upgrade
|
| Asset Writedown | - | - | - | 3.7 | -6.45 | -6.11 | Upgrade
|
| Other Unusual Items | 1.25 | 0.98 | 0.82 | 208.4 | 1.45 | -0.07 | Upgrade
|
| Pretax Income | -1,059 | -1,378 | 151.83 | -231.87 | 519.42 | -255.01 | Upgrade
|
| Income Tax Expense | -0.17 | -0.55 | -0.6 | 1.29 | -0.42 | 9.59 | Upgrade
|
| Earnings From Continuing Operations | -1,058 | -1,377 | 152.42 | -233.16 | 519.84 | -264.6 | Upgrade
|
| Minority Interest in Earnings | 184.52 | 197.44 | 58.77 | 282.58 | 144.33 | 31.1 | Upgrade
|
| Net Income | -873.89 | -1,180 | 211.2 | 49.42 | 664.17 | -233.5 | Upgrade
|
| Net Income to Common | -873.89 | -1,180 | 211.2 | 49.42 | 664.17 | -233.5 | Upgrade
|
| Net Income Growth | - | - | 327.33% | -92.56% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 588 | 588 | 588 | 573 | 547 | 573 | Upgrade
|
| Shares Outstanding (Diluted) | 588 | 588 | 588 | 573 | 547 | 573 | Upgrade
|
| Shares Change (YoY) | -0.00% | 0.05% | 2.55% | 4.78% | -4.46% | -2.80% | Upgrade
|
| EPS (Basic) | -1.49 | -2.01 | 0.36 | 0.09 | 1.21 | -0.41 | Upgrade
|
| EPS (Diluted) | -1.49 | -2.01 | 0.36 | 0.09 | 1.21 | -0.41 | Upgrade
|
| EPS Growth | - | - | 316.73% | -92.89% | - | - | Upgrade
|
| Free Cash Flow | 449.28 | -163.53 | 102.69 | -33.24 | 55.68 | -213.23 | Upgrade
|
| Free Cash Flow Per Share | 0.76 | -0.28 | 0.17 | -0.06 | 0.10 | -0.37 | Upgrade
|
| Dividend Per Share | - | - | 0.035 | 0.032 | - | - | Upgrade
|
| Dividend Growth | - | - | 9.43% | - | - | - | Upgrade
|
| Gross Margin | 38.54% | 37.95% | 40.15% | 41.49% | 39.57% | 39.56% | Upgrade
|
| Operating Margin | -15.44% | -20.12% | -6.41% | -65.25% | -69.06% | -11.03% | Upgrade
|
| Profit Margin | -51.96% | -74.14% | 12.27% | 2.77% | 41.47% | -15.92% | Upgrade
|
| Free Cash Flow Margin | 26.71% | -10.28% | 5.96% | -1.87% | 3.48% | -14.54% | Upgrade
|
| EBITDA | -160.52 | -222.17 | -11.91 | -1,033 | -1,032 | -97 | Upgrade
|
| EBITDA Margin | -9.54% | -13.96% | -0.69% | -57.95% | -64.42% | -6.61% | Upgrade
|
| D&A For EBITDA | 99.13 | 98.05 | 98.4 | 129.98 | 74.26 | 64.8 | Upgrade
|
| EBIT | -259.65 | -320.22 | -110.31 | -1,163 | -1,106 | -161.8 | Upgrade
|
| EBIT Margin | -15.44% | -20.12% | -6.41% | -65.25% | -69.06% | -11.03% | Upgrade
|
| Revenue as Reported | 1,682 | 1,591 | 1,722 | 1,782 | 1,601 | 1,466 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.